Answer
In people with type 2 diabetes, combining liraglutide with insulin and/or sulfonylureas may increase hypoglycaemia risk, which may be lowered by reducing the insulin and/or sulfonylurea dose.
Sources for this answer
- Saxenda 6 mg/mL solution for injection in pre-filled penNovo Nordisk Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked